<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Heart Vessels</journal-id>
      <journal-id journal-id-type="iso-abbrev">Heart Vessels</journal-id>
      <journal-title-group>
        <journal-title>Heart and Vessels</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0910-8327</issn>
      <issn pub-type="epub">1615-2573</issn>
      <publisher>
        <publisher-name>Springer Japan</publisher-name>
        <publisher-loc>Tokyo</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23595779</article-id>
      <article-id pub-id-type="pmc">3948516</article-id>
      <article-id pub-id-type="publisher-id">351</article-id>
      <article-id pub-id-type="doi">10.1007/s00380-013-0351-0</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports</article-title>
        <subtitle>Strategy for ASD with Severe PAH</subtitle>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Taniguchi</surname>
            <given-names>Yu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Emoto</surname>
            <given-names>Noriaki</given-names>
          </name>
          <address>
            <phone>+81-78-3825846</phone>
            <fax>+81-78-3825859</fax>
            <email>emoto@med.kobe-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Miyagawa</surname>
            <given-names>Kazuya</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nakayama</surname>
            <given-names>Kazuhiko</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kinutani</surname>
            <given-names>Hiroto</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tanaka</surname>
            <given-names>Hidekazu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shinke</surname>
            <given-names>Toshiro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okada</surname>
            <given-names>Kenji</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Okita</surname>
            <given-names>Yutaka</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hirata</surname>
            <given-names>Ken-ich</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki Chuo, 650-0017 Kobe, Japan </aff>
        <aff id="Aff2"><label/>Division of Cardiovascular Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>4</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>4</month>
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2014</year>
      </pub-date>
      <volume>29</volume>
      <issue>2</issue>
      <fpage>282</fpage>
      <lpage>285</lpage>
      <history>
        <date date-type="received">
          <day>17</day>
          <month>12</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>4</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2013</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <p>Secundum atrial septal defect (ASD) is the most common form of congenital heart disease in adults. Surgical and transcatheter closures of ASD are widely accepted therapeutic approaches. In patients with severe pulmonary arterial hypertension (PAH), however, the closure of the defect is still controversial. We report two cases of ASD patients with severe PAH successfully repaired subsequent to effective medical therapy. Subsequent shunt closure after targeted medical therapy can be an effective strategy in selected ASD patients with severe PAH.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Atrial septal defect</kwd>
        <kwd>Pulmonary arterial hypertension</kwd>
        <kwd>Pulmonary vasodilators</kwd>
        <kwd>Shunt closure</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Springer Japan 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Secundum atrial septal defect (ASD) is one of the most common forms of congenital heart disease (CHD) in adults. With advancing years, patients become symptomatic and may develop pulmonary arterial hypertension (PAH). Surgical and transcatheter closures of ASD are widely accepted treatments. In patients with severe PAH, however, closure presents the risk of provoking right ventricular failure and pulmonary hypertensive crisis [<xref ref-type="bibr" rid="CR1">1</xref>]. Targeted medical therapies have been established for the treatment of PAH associated with CHD, and they can potentially modify the indication of ASD closure in patients with severe PAH [<xref ref-type="bibr" rid="CR1">1</xref>]. We report two cases of patients with secundum ASD and severe PAH successfully treated with surgical and transcatheter closures subsequent to effective combination medical therapy.</p>
    </sec>
    <sec id="Sec2">
      <title>Case 1</title>
      <p>A 31-year-old woman was referred to our hospital because of exertional dyspnea and syncope. She had felt exertional dyspnea about 2&#xA0;years ago. The World Health Organization (WHO) functional class was III on admission. The 6-min walk distance was 20&#xA0;m terminated by syncope. She had no familial history of PAH. Echocardiography revealed right ventricular dilatation and hypertrophy with secundum ASD (15&#xA0;mm in diameter) with left-to-right shunt. Right heart catheterization (RHC) showed elevated pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR) of 87/30&#xA0;mmHg (mean 57&#xA0;mmHg) and 697 dyn&#xA0;s/cm<sup>5</sup>, respectively. Cardiac output was 5.71&#xA0;l/min estimated by the Fick method. The Qp/Qs ratio was 1.32. We started supplemental oxygen therapy and medical therapy with bosentan (250&#xA0;mg/day) and sildenafil (60&#xA0;mg/day). Two&#xA0;months later, RHC revealed the improvement of PAP and PVR, 60/21&#xA0;mmHg (mean 35&#xA0;mmHg) and 291&#xA0;dyn&#xA0;s/cm<sup>5</sup>. Although medical therapy was effective, the Qp/Qs ratio increased to 2.19 and moderate dyspnea remained. We thought that continuation of medical therapy might further reduce PAP and PVR, but subsequently increase shunt flow, which would insult the pulmonary circulation. Therefore, we performed transcatheter closure 5&#xA0;months after the initiation of medical therapy. After repair, symptoms had improved to WHO functional class I without oxygen administration, and the chest X-ray and echocardiography demonstrated the improvement of right ventricular overload (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). The combination medical therapy was continued after the procedure. RHC performed 6&#xA0;months after closure revealed that PAP was 29/15&#xA0;mmHg (mean 22&#xA0;mmHg) and PVR 197&#xA0;dyn&#xA0;s/cm<sup>5</sup>.<fig id="Fig1"><label>Fig.&#xA0;1</label><caption><p>Chest X-ray and trans-thoracic echocardiogram. Case 1 (<bold>a</bold>&#x2013;<bold>d</bold>) and case 2 (<bold>e</bold>&#x2013;<bold>h</bold>). Cardiomegaly and ventricular overload were dramatically improved after closure (<bold>b</bold>, <bold>d</bold>, <bold>f</bold>, <bold>h</bold>) compared with those on admission (<bold>a</bold>, <bold>c</bold>, <bold>e</bold>, <bold>g</bold>)</p></caption><graphic xlink:href="380_2013_351_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec3">
      <title>Case 2</title>
      <p>A 47-year-old man was admitted to our hospital because of leg edema and exertional dyspnea. He was diagnosed with ASD in childhood, but felt no symptom until 3&#xA0;years ago. WHO functional class was III on admission. Echocardiography revealed right ventricular dilatation, hypertrophy and pericardial effusion with large secundum ASD (36&#xA0;mm in diameter) with left-to-right shunt. RHC showed PAP of 93/29&#xA0;mmHg (mean 60&#xA0;mmHg), PVR of 539&#xA0;dyn&#xA0;s/cm<sup>5</sup> and Qp/Qs ratio of 1.51. We started supplemental oxygen therapy and medical therapy with bosentan (250&#xA0;mg/day), tadarafil (40&#xA0;mg/day) and beraprost (60&#xA0;&#x3BC;g/day). The symptoms improved within 1&#xA0;month to WHO functional class II. PAP and PVR decreased to 58/28&#xA0;mmHg (mean 39&#xA0;mmHg) and 109&#xA0;dyn&#xA0;s/cm<sup>5</sup>, respectively, while the Qp/Qs ratio consequently increased to 3.55. We therefore performed surgical closure 2&#xA0;months after starting the medical therapy. We continued medical therapy with bosentan (250&#xA0;mg/day), tadarafil (40&#xA0;mg/day) and beraprost (60&#xA0;&#x3BC;g/day) after closure. The symptoms had improved to WHO functional class I without oxygen administration. The chest X-ray and echocardiography showed the improvement of the right ventricular overload (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). RHC revealed a PAP of 29/21&#xA0;mmHg (mean 24&#xA0;mmHg), PVR of 190&#xA0;dyn&#xA0;s/cm<sup>5</sup> and Qp/Qs ratio of 1.07.</p>
    </sec>
    <sec id="Sec4" sec-type="discussion">
      <title>Discussion</title>
      <p>Surgical and transcatheter closures are therapeutic standards for ASD. There are few studies reporting the efficacy and safety of the closure in patients with severe PAH [<xref ref-type="bibr" rid="CR2">2</xref>], and the benefit of closure remains controversial. Steele et al. [<xref ref-type="bibr" rid="CR3">3</xref>] have shown that high PVR is associated with poor prognosis in surgically treated patients. Hindi et al. [<xref ref-type="bibr" rid="CR4">4</xref>] have suggested that severe PAH manifested as Qp/Qs &lt;0.7 and PVR&#xA0;&gt;&#xA0;7&#xA0;Woods units are contraindications for transcatheter closure. In these situations, pulmonary vascular disease is thought to be irreversible, and closure of the defect might induce right ventricular failure and pulmonary hypertensive crisis [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>In PAH associated with CHD, targeted medical therapy has been standardized and may induce reverse remodeling of pulmonary arteriopathy [<xref ref-type="bibr" rid="CR5">5</xref>]. Based on these characteristics, medical therapy may have the potential to modify the operability of ASD. The so-called &#x2018;treat-and-repair&#x2019; approach, which implements medical therapy ahead of surgical repair, has been discussed [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>Because of the severity of symptoms, particularly the high PAP and PVR, we first considered our patients inoperable and gave priority to medical therapy. With initial combination therapy, we successfully decreased PAP and PVR in both patients. This effect was achieved in the short term, but the symptoms remained. Further therapy was needed. Given the increased Qp/Qs ratio, additional vasodilators could have induced a further increase in left-to-right shunt and PAP, which would have led to progression of pulmonary arteriopathy. Since the reduction of PVR was rapid, we assumed a strong vasoreactivity of pulmonary arteries. We thus considered the patients operable and decided to close the defects to further reduce PAP. Finally, normal hemodynamics and asymptomatic conditions were attained.</p>
      <p>Several case reports also mentioned the efficacy of treat-and-repair approaches [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. In contrast to these previous studies, we undertook repair after a short-term effective combination medical therapy (2&#x2013;5&#xA0;months). If pulmonary vascular reactivity is preserved, medical therapy will decrease PVR, which may increase pulmonary flow through the defect and insult the pulmonary vasculature [<xref ref-type="bibr" rid="CR1">1</xref>]. Therefore, in case of preserved pulmonary vasoreactivity, early closure of the defect may be safe and prevent further pulmonary vascular remodeling.</p>
      <p>Although Eisenmenger syndrome shares pathological manifestations with idiopathic PAH (IPAH), the prognosis is known to be better than that of IPAH [<xref ref-type="bibr" rid="CR8">8</xref>]. As a reason for this, a right-to-left shunt might act as a relief valve for the right ventricle [<xref ref-type="bibr" rid="CR1">1</xref>]. Similarly, IPAH patients with an incidental ASD also have a better prognosis. These observations argue against the operability of ASD patients with severe PAH because the closure may worsen the prognosis. In case 1, the small size of the defect may indicate that the patient suffered from IPAH with an incidental ASD. Nevertheless, the ASD could be closed successfully, and normal PAP levels were achieved, which may have hindered the progression of pulmonary vascular disease. Based on our cases and previous reports [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], consistent left-to-right shunt and preserved vasoreactivity should be considered prerequisites for safe and effective repair of ASD in PAH patients.</p>
      <p>We presented two cases of successful treatment for ASD and severe PAH with short-term powerful combination medical therapy ahead of the closure. Even though this approach cannot be generalized, subsequent shunt closure after medical therapy should be considered effective in selected patients with ASD and severe PAH. Clinical studies are required to evaluate the efficacy and safety of this strategy.</p>
    </sec>
  </body>
  <back>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dimopoulos</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Peset</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gatzoulis</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy</article-title>
          <source>Int J Cardiol</source>
          <year>2008</year>
          <volume>129</volume>
          <fpage>163</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2008.02.004</pub-id>
          <pub-id pub-id-type="pmid">18367267</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>ZW</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>ZX</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Gao</surname>
              <given-names>YQ</given-names>
            </name>
            <name>
              <surname>Geng</surname>
              <given-names>YM</given-names>
            </name>
            <name>
              <surname>Niu</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>BX</given-names>
            </name>
          </person-group>
          <article-title>The short- and medium-term results of transcatheter closure of atrial septal defect with severe pulmonary arterial hypertension</article-title>
          <source>Heart Vessels</source>
          <year>2012</year>
          <volume>27</volume>
          <fpage>603</fpage>
          <lpage>609</lpage>
          <pub-id pub-id-type="doi">10.1007/s00380-011-0187-4</pub-id>
          <pub-id pub-id-type="pmid">21927863</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Steele</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Fuster</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>McGoon</surname>
              <given-names>DC</given-names>
            </name>
          </person-group>
          <article-title>Isolated atrial septal defect with pulmonary vascular obstructive disease&#x2014;long-term follow-up and prediction of outcome after surgical correction</article-title>
          <source>Circulation</source>
          <year>1987</year>
          <volume>76</volume>
          <fpage>1037</fpage>
          <lpage>1042</lpage>
          <pub-id pub-id-type="doi">10.1161/01.CIR.76.5.1037</pub-id>
          <pub-id pub-id-type="pmid">3664992</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Hindi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>QL</given-names>
            </name>
            <name>
              <surname>Hijazi</surname>
              <given-names>ZM</given-names>
            </name>
          </person-group>
          <article-title>Transcatheter closure of secundum atrial septal defect in the elderly</article-title>
          <source>J Invasive Cardiol</source>
          <year>2009</year>
          <volume>21</volume>
          <fpage>70</fpage>
          <lpage>75</lpage>
          <pub-id pub-id-type="pmid">19182295</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galie</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Beghetti</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gatzoulis</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Granton</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Lauer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chiossi</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Landzberg</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study</article-title>
          <source>Circulation</source>
          <year>2006</year>
          <volume>114</volume>
          <fpage>48</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.630715</pub-id>
          <pub-id pub-id-type="pmid">16801459</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tahara</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mizoguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Honda</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Tahara</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nitta</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kodama</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Koiwaya</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aoyagi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Imaizumi</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan</article-title>
          <source>Int J Cardiol</source>
          <year>2012</year>
          <volume>158</volume>
          <fpage>e38</fpage>
          <lpage>e40</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ijcard.2011.10.027</pub-id>
          <pub-id pub-id-type="pmid">22078398</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>YH</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Yun</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>YB</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Jhang</surname>
              <given-names>WK</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Seo</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Ko</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>Repair of atrial septal defect with Eisenmenger syndrome after long-term sildenafil therapy</article-title>
          <source>Ann Thorac Surg</source>
          <year>2010</year>
          <volume>89</volume>
          <fpage>1629</fpage>
          <lpage>1630</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2009.10.027</pub-id>
          <pub-id pub-id-type="pmid">20417794</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hopkins</surname>
              <given-names>WE</given-names>
            </name>
            <name>
              <surname>Ochoa</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Richardson</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Trulock</surname>
              <given-names>EP</given-names>
            </name>
          </person-group>
          <article-title>Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome</article-title>
          <source>J Heart Lung Transplant</source>
          <year>1996</year>
          <volume>15</volume>
          <fpage>100</fpage>
          <lpage>105</lpage>
          <pub-id pub-id-type="pmid">8820089</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sachweh</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Daebritz</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Hermanns</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fausten</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jockenhoevel</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Handt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Messmer</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect</article-title>
          <source>Ann Thorac Surg</source>
          <year>2006</year>
          <volume>81</volume>
          <fpage>207</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="doi">10.1016/j.athoracsur.2005.07.053</pub-id>
          <pub-id pub-id-type="pmid">16368366</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
